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ABSTRACT The two-component ﬂavoenzyme styrene monooxygenase (SMO) is an efﬁcient alternative to several chemical
epoxidation catalysts on a preparative scale. A ﬁrst homology model of the catalytic domain (StyA) of SMO was constructed
(Protein Data Bank ID 2HD8) based on the structure of para-hydroxybenzoate hydroxylase. The StyA protein structure was
optimized by restrained molecular dynamics to reproduce speciﬁc pre-S binding orientations of styrene. Effects of all 10 point
mutations examined were explained by the distance of the site to the styrene and FAD binding sites. Thirteen of 20 ligands
could be accommodated in a catalytically active binding orientation, and predicted afﬁnities correlated well with experimental
turnover and inhibition. The binding cavity is almost completely hydrophobic except for a hydrogen-bonded network formed by
three water molecules, the backbone of residues 300–302, and the ﬂavin ribityl, similar to P293, and three crystal waters in
para-hydroxybenzoate hydroxylase suggest that P302, T47, and the waters in StyA are a vital component of the catalytic
mechanism. The current optimized and validated StyA model provides a good starting point for elucidation of the structural
basis of StyA ligand binding and catalysis. Novel insights in the binding of ligands to SMO/StyA, provided by the current protein
model, will aid the rational design of mutants with speciﬁc, altered enantioselective properties.
INTRODUCTION
Recently, interest in the class of two-component ﬂavoenzyme
hydroxylases has emerged (1,2). Two-component ﬂavo-
enzymehydroxylases consist of a smaller reductase component
that uses NAD(P)H to reduce ﬂavin and a larger hydroxylase
component that uses the reduced ﬂavin to perform the
hydroxylation reaction. Styrene monooxygenase (SMO)
from Pseudomonas sp. VLB120 is such a two-component
ﬂavoenzyme, consisting of a larger oxygenase domain StyA
and a smaller reductase domain StyB, each with an indepen-
dent catalytic center (2–4). StyA is not dependent on its native
reductase; also, different reductases, chemical mediators that
generate reduced ﬂavin, and even direct electrochemical
reduction on an electrode can be used as electron donor (3,5).
The SMO enzyme is highly enantioselective, producing
.99% enantiopure S-styrene oxide. Of further interest is the
development of methods to rationalize and design mutants
with altered substrate and/or enantioselectivity (6), which can
provide a basis to explore possibly interesting applications in
the chiral synthesis of epoxide building blocks for pharma-
ceuticals or agrochemicals (1). For this purpose, a structural
model of the protein based on crystallographic data or from
homology model building is indispensable. The class of
ﬂavoenzymes is well studied (2,7,8). For 50 FAD-containing
oxidoreductase/hydroxylases there are x-ray structures in the
ProteinData Bank (PDB) (9), but for SMOno x-ray structures
have yet been published.
The current article describes a newly constructed, opti-
mized, and validated homology structure of the StyA
oxygenase component of SMO, deposited in the PDB under
ID 2HD8 (9). Some general features of the binding cavity
were described before, based on a preliminary StyA model
(5), but that model was not capable of accommodating
substrates in a catalytically active position, nor could it be
used to describe or explain substrate binding in detail. For
further optimization and for validation of a StyA protein
model, experimental data on binding afﬁnity and enzyme
turnover for a range of substrates and for selected site-directed
mutants were used. The construction and analysis of the
current StyA structure comprise a vital step in the rational-
ization of activity and (enantio)selectivity of catalysis by
StyA wild-type (WT) and mutants.
METHODS
Sequence alignment
The primary sequence of StyA (accession code O50214) was obtained from
the Sequence Retrieval System accessible from the EMBL (www.embl-
heidelberg.de). The search for homologous sequences with resolved crystal
structure was carried out using BLAST (10), yielding para-hydroxyben-
zoate hydroxylase (pHBH), PDB identiﬁer (9) 1PBE (11), and 2-phenol-
hydroxylase (PhHy), PDB identiﬁer 1FOH (12). A multiple sequence
alignment (MSA) of StyA with pHBH and PhHy was manually made based
on conserved sequence motifs and substrate recognition sites (SRSs) in
ﬂavoproteins (see Table 1) (13), with the homology module of InsightII
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(Biosym, San Diego, CA). Further alignment was done on consensus using
LOOPP (14). The MSA was reﬁned using data on amino acids relevant for
the binding of FAD (Table 2) (11,15–17). Ten different 3D strucures of StyA
were generated with the restraint-based comparative modeling program
Modeller 4.0 (18). From the structures generated by the Modeller program,
the one with the best loop conformations and stereochemical parameters as
determined by ProCheck (19) was selected for further modeling.
Protein structure optimization
An optimization scheme employing steepest descents energy minimization
(EM) and molecular dynamics (MD) simulations with positional restraints
applied to different sets of atoms was used, which could be described as a
‘‘controlled release’’ method. The Gromacs MD package, version 3.1.4
(20,21), and the GROMOS 43a1 forceﬁeld (22,23) were used with a 0.8/1.2-
nm cutoff and a neighbor list update frequency of ﬁve steps. The LINCS
algorithm (24) was used to constrain the length of all covalent bonds, and a
time step of 2 fs was used. The protein structure, including the substrate
styrene and cofactor FAD, was energy minimized in vacuum, ﬁrst with
harmonic position restraints on all nonhydrogen atoms with a force constant
of 1000 kJ/mol/nm and then without position restraints. Subsequently,
preequilibrated simple point-charge (SPC) water was added in a periodic
dodecahedral box with a minimum distance of 1.2 nm between the protein
and box edges, and the system was minimized again. Starting velocities were
randomly generated from a 300 K Maxwell distribution. Temperature was
maintained at 300 K and pressure at 1 bar by weak coupling to a bath using
relaxation times of 1 ps and 0.1 ps, respectively.
During a 1-ps MD run the water was allowed to relax while the whole
protein was position restrained with a force constant of 1000 kJ/mol/nm. In a
series of short MD runs, subsequent parts of the protein were allowed to relax
by removing the position restraints for the appropriate atoms. First, the side
chains only of the residues not involved in either FADor styrene bindingwere
released for 1 ps. Next, also the backbone of the binding residueswas released
for 10 ps. During this whole procedure the positions of both FAD and styrene
were also restrained. Finally, only the backbone atoms of the binding residues
were restrained for 100 ps, while the rest of the protein as well as FAD and
styrene were ‘‘free’’. The set of binding residues was deﬁned as all residues
that had at least one atom closer than 6 A˚ to one atom of either FAD or styrene
in the nonoptimized structure. These were Ala13, Glu38, Tyr39, Arg43, Thr47,
Val48, Glu113, Ala209, Val211, Leu220, Val222, Ala224, Arg233, Phe235, Asp295,
Pro302, Gly305, Ala308, Asn309, and Phe409 and include all known FAD-
interacting residues, as listed in Table 2, with the exception of Asp33. Several
1-ns-long MD simulations without position restraints were performed with
styrene and FADbound in the StyAprotein: six started from the nonoptimized
structure and six from the optimized structure, each with a different starting
velocity randomly generated from a 300 K Maxwell distribution. Dynamic
stability of the structure before and after the procedure was assessed by deter-
mining the atomic position root mean-square deviation (RMSD) with respect
to the starting structure, averaged over the ﬁnal 0.5 ns of each simulation, and
differences in dynamic behavior are assessed from ED projections of the
trajectories on the ﬁrst two eigenvectors of all trajectories combined (25,26).
Candidate model structures were extracted from the 1-ns MD simulations
started from the optimized structure by taking average structures over the
ﬁrst 100 ps and over the last 100 ps of the trajectories and energy minimizing
to remove unphysical geometries that might result from the averaging, and
the substrate styrene was removed. This resulted in a total of 12 candidate
structures. Subsequently the substrate styrene was docked into each of the
candidate structures. The optimal candidate was selected based on the pos-
sibility of reactivity of the docked conformations as judged from the distance
to the reactive carbon atom FC4A in the FAD cofactor, the correct
prochirality of the docked orientations of styrene as judged from the angle
between the styrene plane and that of the isoalloxazine ring of FAD, and the
speciﬁcity of the docked conformations as judged from the RMSD between
different docked conformations within one structure.
StyA mutant structures
Structural models of 14 single (point) mutants of StyA were generated:
V274Y/C/H, P275H/A, P302A/H, A298H, F409S, T12P/H, Q341R, L45C/
H, and F173H. From the WT StyA structure, the selected amino-acid side
chains were replaced by the mutant forms using the maximum overlap
principle (retaining all overlapping atoms between WT and mutant residue)
(27). The resulting structures were energy minimized to remove unfavorable
interactions between the modiﬁed side chains and the surrounding protein.
TABLE 2 FAD interacting residues in pHBH with correspondingly aligned residues in StyA, and secondary structure elements
pHBH StyA Location Postulated function Reference
Ser13 Ala13 bA3-aH1 NH of Ala13 H-bonded with FO2 (Pi of FAD), cf. Ser
13 in pHBH (11)
Glu32 Asp33 bA2 Conserved D/E. Stabilizes FAD (16)
Arg44 Arg43 aH2-bE1 H-bonded with AOP1 of FAD (13)
Gln102 Glu113 aH6 H-bonded with FOB of FAD (11)
Arg220 Arg233 bB5 Stabilizes out position of FAD in pHBH (17)
Binding of FADred in StyA (putative) (38)
Asp286 Asp295 bA5-bD3 H-bonded with O-F1 (
FOG),
FOP2 of FAD (11)
Pro293 Pro302 bD3-aH10 Conserved, structural; postulated catalytic role in stabilizing
transition state of hydroxylation of PhHy (P364)
(15)
P302 mutants have reduced stability (5)
Leu299- Asn300 Ala308-Asn309 aH10 Amides H-bonded to ﬂavin ring (11)
FAD atoms are indicated according to Gatti et al. (17).
TABLE 1 Conserved sequence motifs in ﬂavoproteins used for aligning StyA to pHBH
Motif StyA Location Description Reference
GxGxxG 9–14 bA3–aH1 Postulated structural function for interaction adenosyl-ribose
and b-a-bend of terminal bab
(29,36)
DG 170–171 loop bA4-aH7 Only : ‘‘G’’ conserved in StyA (13)
GDx6P 294–302 bD3 Putative dual function in FAD/NAD(P)H binding in
ﬂavoprotein hydroxylases
(13)
GxNx8L 307–318 aH10 Conserved sequence motif (13)
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Substrate binding conformation prediction
Twenty substances (styrene, 1,2-dihydronaphthaline, 3/4-bromo/chloro/
methyl/nitro-stryrene, a/b-methyl-styrene, indene, 1-phenyl-1-cyclohexen,
2/4-vinylpyridine, allylbenzol, 1,3-cyclo-hepta-/octadiene, naphthalene,
vinylcyclopentane) were docked into the StyA protein structure using the
automated docking program Gold (28). Of each compound, 50 docked
conformations were generated and analyzed in terms of ‘‘active’’ binding,
i.e., at the right distance and orientation with respect to the reactive carbon
atom FC4A of FAD. Amaximum distance of 6.5 A˚ was taken, based on
FC4A-
Op-Od bond lengths and estimates of distances in the reaction coordinate (15).
The prediction of active binding was correlated with measured activities of
these substrates to validate details of the active site geometry and chemical
composition as well as the bound orientation of the FAD cofactor (29).
Substrate binding afﬁnity prediction
The binding free energy (DG) of styrene and several of the other substrates
for the StyA WT and mutant proteins were calculated using the linear
interaction energy (LIE) approximation (30,31) as follows,
DGCalc ﬃ aðEVdW;bound  EVdW;freeÞ1bðECoul;bound  ECoul;freeÞ;
(1)
where EVdW,bound and ECoul,bound are the van der Waals and the Coulomb
interaction energies, respectively, between the substrate and its surroundings
in the bound state, i.e., protein, FAD, and water, and EVdW,free and ECoul,free
between substrate and surroundings in the free state, i.e., only water. These
energies are obtained fromMD simulations of the respective states, and error
margins of the calculated DG are obtained from the respective energy
ﬂuctuations during the simulations. Using the solvent-accessible surface
area of styrene calculated using the program MSMS (32) and the method
proposed by Wang et al. (33) based on the correlation between weighted
nonpolar desolvation ratio (WNDR) and a, an a of 0.98 was obtained. For
the calculation of binding afﬁnities for uncharged ligands without hydroxyl
groups, the suggested value of 0.43 for b is used (34). From the free energy
of binding (DGCalc), the binding afﬁnity is calculated as follows,
Kd;Calc ¼ expðDGCalc=kBTÞ; (2)
where kB is Boltzmann’s constant and T ¼ 300 K.
Selected docked conformations according to the criteria mentioned above
of styrene, 3-/4-/a-/b-methylstyrene, 2-/4-vinylpyridine, vinylcyclopentane,
1,2-dihidronaphthaline, indene, and naphthalene, for the StyA-substrate com-
plexes of WT and for styrene in theWT and the F235A/S, V274C, P275A/H,
P302A/H, and F409S mutants were energy minimized, solvated, and equil-
ibrated as described under Protein structure optimization. Four hundred pico-
seconds of production MD simulations were performed, and average
interaction energies were collected over the ﬁnal 300 ps. For interaction
energies of the free substrate in solvent, the same procedure was followed,
with 100 ps of productionMD simulation and energies averaged over the last
50 ps.
RESULTS
StyA sequence alignment
A homology model of StyA (SMO catalytic domain) was
constructed based on the x-ray crystallographic structure of
pHBH, the closest homolog to StyA with 23% pairwise
sequence identity. An overview of this protein model is
presented in Fig. 1 A. The higher local similarity with PhHy
(pairwise identity 22%) was also used for the MSA.
Conserved motifs are summarized in Table 1. The conserved
sequence motif GxGxxG (StyA residues 9–14) is thought to
play an important role in the interaction with the ribose of the
adenosyl moiety of FAD in pHBH (35) and in FAD-binding
proteins in general (29,36). It is localized in the structurally
conserved b-a-b unit at the C-terminal end of hydroxylases
and monooxygenases (13). The short DG motif is located in
loop bA4-aH7 of the FAD-binding domain of pHBH and is
situated near the cleft leading toward the active site (13); in
StyA only the Gly171 is conserved. The GDx6P motif (StyA
residues 294–302) is conserved in ﬂavoprotein hydroxylases
with a putative dual function in FAD and/or NAD(P)H
binding (13) and is located in strand bD3 (note that StyA
binds FAD, not NAD(P)H). The conserved GxNx8L motif
(13) corresponds to StyA residues 307–318 and is located in
helix aH10. Further alignment was done on consensus using
the LOOPP program output (14).
The MSA was reﬁned by comparing the FAD binding
residues in pHBH (11,13,15,16) (see Table 2) with residues in
StyA. Ala13, Asp33, Arg43, Glu113, Arg233, Asp295, Pro302,
Ala308, and Asn309 in StyA were found to correspond with
Ser13, Glu32, Arg44, Gln102, Arg220, Asp286, Pro293, Leu299,
and Asn300 in pHBH, respectively. The complete MSA of
pHBH, PhHy, and StyA is presented in Table 3. In this ﬁnal
MSA between StyA and pHBH, 173 (38%) are strongly con-
served (conservation score $8, e.g., Val-Ala, see Table 3).
In Table 4, the effects of the single amino-acid substitutions
V274Y/C/H, P275H/A, P302A/H, A298H, F409S, T12P/H,
Q341R, L45C/H, F173H in the StyA protein on the activity of
the enzyme are listed as well as the closest separation between
any of the atoms of the corresponding amino acids in the
model structure and styrene and FAD. These respective
residues are shown in Fig. 1 B in relation to the location of
styrene and FAD in themodel. For all residues closer than 5 A˚
to either styrene or FAD (T12, L45, V274, P302 and F409), a
large effect of at least one of the substitutions (,50% activity
versus wild-type) was observed. Conversely, mutations in
residues at more than 5.5 A˚ from styrene and FAD (F173,
P275, A298, and Q341) showed small effects of all substi-
tutions (at least 50% activity versus wild-type). In addition,
for mutations in six positions, the stabilization of bound re-
duced FADwas determined (see Table 4), and it was changed
by at least one mutation in ﬁve of them (T12, L45, F173,
F235, and P302), all closer than 5.5 A˚ to FAD in the model.
With the effects of all 10 mutated residue positions in StyA
explained by distances in the StyAmodel structure, the align-
ment of the StyA sequence to the template structures pHBH
and PhHy is properly validated, especially in the most impor-
tant areas of the enzyme: the binding sites of styrene and FAD.
StyA structure and optimization
The initial proteinmodel structurewas found to bemoderately
stable in EM and MD simulations (20–23), with Ca atoms
RMSDwith respect to the starting conformation rising during
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six 1-ns freeMD simulations to plateau values of 4.26 0.5 A˚.
The Ca atomRMSD between the protein structure before and
after the controlled-release optimization was 2.8 A˚ for the
whole protein (3.4 A˚ for all atoms) and 0.9 A˚ for theCas of the
active site only (1.7 A˚ for all atoms). The optimized protein
structure was more stable with corresponding RMSD plateau
values of 3.6 6 0.3 A˚ during six 1-ns free MD simulations,
which indicates a good dynamic stability for a protein of this
size and type on a timescale of nanoseconds. The Ca RMSD
plateau of the binding residues was reduced from 2.06 0.3 A˚
in the simulations before optimization to 1.5 6 0.3 A˚ in the
simulations after optimization. This indicates a good dynamic
stability of the active site region. Six candidate model struc-
tures were extracted from six simulations of the optimized
structure by averaging the conformations of the ﬁrst 100 ps,
and another six structures from the ﬁnal 100 ps. ProCheck
analysis (19) of the distribution of backbone dihedral angles
of these candidate structures indicated the structures after the
optimization simulations still possessed good stereochemical
quality (19): in all cases 946 1% of residues were in core or
allowed regions. Table 5 shows a summary of Ramachandran
distributions at different stages in the optimization. For the
initial model, 78% of main-chain bond lengths were within
limits, and two were off the graph; for all other models 100%
were within limits. As a general trend, it was observed that,
during the ﬁve stages of the controlled-release optimization,
the quality decreased somewhat; i.e., the Ramachandran plot
shifted from 74% core and 20% allowed to 63% and 32%,
respectively. However, much of this decrease was made up
again by taking the minimized average structure over 100 ps
of simulation in the ﬁnal stage.
In Fig. 2, the essential dynamics (ED) projection (25,26) is
shown for the changes in the protein and active site structure
on optimization and during the MD simulations. Distances
between two points in this plot are closely related to the
familiar RMSDmeasure, but in addition, differences between
the trajectories visualize motion in different directions.
Motions along the two axes in the plot correspond to the
two largest collective modes of motion of the enzyme, also
known as ‘‘essential modes’’ (25). This illustrates the
difference in behavior between the simulations started from
the nonoptimized structure and those started from the
optimized structure. The stretched appearance of the traces
of the nonoptimized simulations is caused by a ballistic type
ofmotion indicative of high internal strain in the protein struc-
ture and corresponds to the high RMSDplateau level of 4.26
FIGURE 1 StyA, the substrate styrene (STY)
and the cofactor FAD. (A) Overview of the whole
StyA structure. Secondary structure elements are
labeled according to the template pHBH (11). (B)
Mutated residues around the StyA active site
described in this study. Orange lines indicate the
closest distances between the mutated residues
and styrene or FAD. (C) Styrene binding in the
StyA active site. The styrene binding cavity
surface is shown, and the frontmost part is clipped
to allow an inside view. Bound waters are
highlighted with transparent blue spheres. The
catalytic FC4A in the isoalloxazine ring of FAD
and the vinyl group of Sty are highlighted in
orange; the line in between shows their relative
orientation. Hydrogen bonds among FAD, bind-
ing residues, and water are indicated with dashed
yellow lines.
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0.5 A˚ for the whole protein and 2.06 0.3 A˚ for the active site.
In the projection of the whole protein, the difference in the
nonoptimized and optimized structures of 2.9 A˚ can be seen as
a shift of the starting point of the corresponding simulations,
whereas in contrast, in projection of the active site, the smaller
structural shift of 0.9 A˚ is hardly visible. The optimized
structure, in contrast, shows a much more diffusive nature of
the projections of the simulations, which is indicative of a
protein structure with native-like properties (37) and corre-
sponds to the lower RMSDs of 3.66 0.3 A˚ and 1.56 0.3 A˚
for protein and active site, respectively.
Of all optimized StyA protein structures, the predictions
from automated docking showed one structure to bind sty-
rene in a single tight cluster with a maximum RMSD
between members of the cluster of 0.5 A˚, in a catalytically
active position with respect to the FAD cofactor reactive
center (,6.5 A˚ between the ethylene of styrene and FC4A,
see Fig. 1 C), and an orientation prochiral to the formation of
S-styrene oxide exclusively. In the other structures, styrene
was bound in a noncatalytically relevant position, in widely
varying positions, or in a mixed prochiral orientation. No
protein structure was found that would support exclusive
pro(R) orientation. The one structure showing the correct,
tight, and pro(S) binding characteristics for styrene was
chosen for subsequent validation. The ﬁnal StyA structure is
shown in Fig. 1 A, and details of the styrene binding pocket
and the bound orientation of styrene are shown in Fig. 1 C.
StyA structure validation
Binding free energies (DG) for styrene in the wild-type (WT)
StyA and themutants F235A/S, V274C, P275A/H, P302A/H,
and F409S were calculated from MD simulations using the
LIE method, using Eq. 1 (30,31). The docked orientation of
styrene in the StyAWT structure was also used as the starting
orientation for the MD simulations in the mutant structures
(see Fig. 1,A andC). Calculated free energies (DG) of binding
are listed in Table 4. The average distances between the
catalytically active carbon FC4A of FAD and the vinyl group
of styrene (see Fig. 1 C) are listed in Table 4. A distance of
,6.5 A˚ can be considered reactive (15).
In Table 6, experimental activities classiﬁed as high
(.20%), low (1–20%), or no activity (,1%) relative to
styrene for the 20 selected styrene-homologous substrates are
TABLE 3 Multiple sequence alignment (MSA) among StyA (SMO_LV12), pHBH (1PBE), and PhHy (1FOH) as produced by CLUSTALW (1.82)
On light and medium gray background the conserved sequence motifs (Table 1) are indicated, and on boxed gray the FAD binding residues based on the
crystal structure of pHBH (1PBE) (Table 2). Identical residues are indicated by a dark gray background, lighter if only two of three match. Secondary
structure elements ( for a-helix and for b-sheet) in the StyA structure are indicated, and labeled according to the pHBH template (11). Conservation
scores for the alignment are indicated on a scale from 1 to 9 and1 for nearly and * for completely identical, respectively, as calculated by JalView 2.06 (41).
Finally, the consensus sequence is shown.
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listed. Sixteen of these could be docked at a distance to the
catalytically active carbon FC4A and in an orientation with
respect to the isoalloxazine ring of FAD, corresponding to
an active conformation. However, 3-bromo-, 4-chloro-, and
3- and 4-nitrostyrenewere predicted by the docking algorithm
to bind in an orientation relative to FAD inwhich the aromatic
rings were stacked.
For styrene, 3-, 4-, a- and b-methylstyrene, 1,2-dihydro-
naphthaline, naphthalene, indene, 2- and 4- vinylpyridine,
vinylcyclopentane, allylbenzol, and1,3-cycloheptadienebinding
free energies (DG) were determined using the LIE method
and are listed in Table 6. In Fig. 3, it can be seen that in
general the substrates with low activity have low predicted
binding afﬁnities (#8.7 kcal/mol), whereas most with
TABLE 4 Mutants of StyA, shortest distances between atoms of the mutated residues and the styrene (Sty) and FAD binding pockets
in the protein structure, measured relative activities, and binding afﬁnities of reduced FAD, average distances between FC4A of FAD and
the vinyl carbons (CH) of styrene during LIE-MD simulations, and calculated free energies (DGCalc) for styrene in selected mutants
Distances (A˚)
Mutation Sty FAD Rel. act. (%)y FADred binding
yz Aver. dist. FC4A-CH (A˚)
y§ DGCalc (kcal/mol)
y{
WT — — 100 4.1 6 0.4 9.1 6 1.2
T12H 13 1.8 ,1*  — —
T12P 13 1.8 20 — — —
L45C 4.6 2.9 17 . — —
L45H 4.6 2.9 11 ; — —
F173H 13 5.3 ,1*  — —
F235A 2.8 2.6 — — 6.2 6 0.7 9.0 6 1.9
F235S 2.8 2.6 — — 7.4 6 1.3 8.4 6 1.5
F235V 2.8 2.6 1 ; — —
F235Y 2.8 2.6 31 , — —
V274C 6.1 3.9 90 — 7.5 6 0.4 10.1 6 1.1
V274H 6.1 3.9 10* — — —
V274Y 6.1 3.9 100 — — —
P275A 7.7 6.3 65 — 7.4 6 0.5 9.3 6 1.2
P275H 7.7 6.3 110 — 7.9 6 0.3 9.4 6 1.3
A298H 13 5.9 55 — — —
P302A 3.3 4.1 10*  6.5 6 0.5 8.8 6 1.3
P302H 3.3 4.1 ,10* — 9.7 6 0.3 12.5 6 1.3
Q341R 18 13 100 — — —
F409S 5.3 5.5 70 ; 7.9 6 0.5 9.0 6 1.3
*Inclusion bodies formed.
y’’‘—’, ‘not determined’.
zMore ‘.’, similar ‘;’, less ‘,’ or much less ‘’ than wild type.
§Average distances between FAD catalytic C4A and styrene ethylene atoms during LIE-MD simulations.
{Error margins derived from energy ﬂuctuations during the MD simulations.
TABLE 5 ProCheck Ramachandran distributions and other quality factors for the StyA structures in various stages of optimization
and for the ﬁnal model
Ramachandran* MCB angle*y Planar groups* G-factors
Stage Core Allowed Generous Disallowed
Bad
contacts
Within
limit Highlight
Off
graph
Within
limit Highlight
Off
graph Dihedrals Covalent Overall
Initial model 74 20 4.5 1.7 30 60 40 13 98 2 0 0.46 0.8 0.57
Minimized 77 16 4.7 1.9 2 61 39 3 40 60 28 0.71 0.26 0.49
Solvation 72 23 3.3 1.7 6 49 51 5 24 76 61 0.97 1.27 0.99
Side chain relax 66 28 4.2 1.9 4 52 48 1 30 71 49 1.03 1.13 0.98
Binding site sc 65 30 2.5 1.9 7 51 49 5 28 72 48 0.92 1.21 0.94
Binding site relax 63 32 2.8 2.8 3 52 48 3 31 69 48 0.86 1.04 0.84
Candidates
‘1st 100 ps’
69 6 0.7 26 6 1.3 1.9 6 0.7 3.1 6 0.2 1 6 0.6 76 6 1.2 24 6 1.2 0 57 6 3 43 6 3 19 6 1.3 –0.60 6 0.01 0.075 6 0.005 –0.31 6 0.008
Candidates
‘Last 100 ps’
67 6 2.2 27 6 2.4 2.6 6 0.7 3.0 6 0.4 0.8 6 0.8 74 6 1.5 26 6 1.5 0 57 6 4 43 6 4 18 6 4 –0.60 6 0.02 0.05 6 0.02 –0.32 6 0.02
Final model 70 25 1.4 3.3 1 78 22 0 56 44 20 0.62 0.08 0.32
For the candidate ﬁnal models, six from the ﬁrst and six from the last 100 ps of the simulations (see text for details), average values and standard deviations
are listed.
*Percentage within region indicated.
yMain chain bond—angles.
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higher activity (‘‘1’’ or ‘‘o’’) have higher afﬁnity ($8.7
kcal/mol). For the individual substrates, however, the error
margins are such that the differences are not signiﬁcant.
Finally, the relatively high inhibition of styrene catalysis by
4- and b-methylstyrene and the relatively low inhibition by
a-methylstyrene determined experimentally, are reproduced
by the calculated (relative) binding afﬁnities of these sub-
strates (see Table 6). The ﬁnal StyA structure has been depos-
ited in the PDB under ID 2HD8.
Structural features of styrene, FAD, and water
binding in StyA
Styrene binds in the StyA binding pocket stacked with Phe235
at the bottom andwithVal303 at the top, as is shown in Fig. 1C.
Leu220 and the di-methyl-phenyl ring of FADmake up the left
and right sides of the binding pocket, respectively. Finally,
Ile198 makes up the front, and Val222 and the hydroxyl group
of Thr47 the rear side. Of these six residues, ﬁve are at;3.5 A˚
from styrene, whereas Val303 and FAD are at ;4 A˚. Thr47 is
the only polar side chain in the styrene binding pocket. It is in a
position close to the catalytic FC4A of FAD and the ethylene
group of styrene, where it may be involved in stabilization of
an intermediate in the reaction. Ten additional residues can be
found that have at least one atom within 6.0 A˚ of styrene,
shown as well in Fig. 1 C, but none of these has any hydro-
philic parts within 6 A˚ of styrene. Furthermore, the backbone
carbonyls of Ile198, Leu220, Pro302, andVal303 are located inside
the pocket. These active site residues and secondary structure
elements are summarized in Table 7. In the strongly hydro-
phobic StyA styrene binding cavity, no water is present at all.
A putative substrate access channel can be identiﬁed going
through the FAD binding site, which is blocked when FAD is
bound.
The interactions of FADwith StyA are shown in Fig. 4. The
isoalloxazine ring is H-bonded to Thr47, Val48, and Asn309,
and additional H-bonds are formed with Ala13, Asn46, and
Ala308 (not shown). Hydrophobic contacts are made with
Gln306 and Gly307, and additionally with Leu45 and Gly305
(not shown). The ﬂavin ribityl hydroxyl groups are H-bonded
to the pyrophosphate and to Glu113, Asp295, and some water
molecules (not all waters are shown). The pyrophosphate is
H-bonded to Thr12, via water to Arg34, and in addition to
Arg43 (not shown). The adenosine ribose is H-bonded to the
backbone of Arg34 and additionally to Asp33 and the back-
bone of Ala10 and Gly11. Finally, the adenine double ring is
H-bonded toLeu139 andLys174 (not shown) andmakes hydro-
phobic contacts withArg34. The front (as in Fig. 4) of the FAD
binding pocket of StyA is open and accessible to the solvent;
;16watermolecules hydrate the boundFAD, several ofwhich
are worth mentioning. A string of three waters runs from the
active site along the backbone carbonyls of Pro302, Asp301,
Glu306, and Gly307 to the ribityl of FAD. Twowaters meditate
H-bonds between Arg34 and Asp295 and the ribityl and pyro-
phosphate, and three more (not shown) extend this H-bonded
network. An additional three waters (not shown) mediate
H-bonds between the adenine and Leu138, Leu139, andGlu178.
DISCUSSION
StyA structure building and optimization
We have examined the substrate binding of the oxygenase
domain (StyA) of the styrene monooxygenase enzyme from
Pseudomonas sp. VLB120, in its wild-type form and several
site-directed mutants, using a newly constructed homology
model. For this purpose, ligand binding orientations and
afﬁnities were predicted for the wild-type StyA and 17
mutants and for 20 other substrates for the wild-type StyA.
The predictions were used to rationalize the observed relative
activities of styrene catalysis determined experimentally.
The StyA protein model was based on the crystallized
para-hydroxybenzoate hydroxylase (pHBH) and 2-phenol
hydroxylase (PhHy). The pairwise identity between pHBH
and StyA was high enough (23%) to make homology model-
ing feasible and was further facilitated by the strong sequence
similarity between pHBH and StyA of ;38% (conservation
FIGURE 2 MD simulations for opti-
mization and evaluation of optimized
structures projected onto the two essen-
tial modes (the two largest principal
eigenvectors) of (a) Ca positions of
all 415 residues of the protein; and (b)
Ca positions of the binding residues
only. The dotted lines indicate differ-
ences in conformation before and after
the controlled-release optimization pro-
cess. These are prominent for the whole
protein but hardly visible for the active
site. Note the difference in scale be-
tween the plots.
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score $8 in the MSA of Table 3). Strongly conserved struc-
tural and functional features within the oxidoreductase en-
zyme family can be traced down to several key patterns of
conservation (Table 1) (13,29), certainly for the most impor-
tant active site region of the enzyme (Table 2) (11,15–17,38),
lending additional reliability to the alignment. All known
pHBH active site residues were very strongly conserved
throughout the MSA (conservation score$8 in Table 3), and
their counterparts in the StyA sequence (Table 2) could be
incorporated in the active site region of the StyA protein
structure (Fig. 4). For several additional residues that are
known to inﬂuence the StyA catalytic function (5), their close
proximity to the substrate and/or cofactor is shown (Table 4).
This ﬁrst StyA homology model has been demonstrated
to be stable in MD simulations (Fig. 2). For the whole StyA
protein, the change in structure from the nonoptimized to
the optimized structure is rather large (2.9 A˚ RMSD on Ca),
whereas for the active site only, the concomitant structural
shift is relatively small (1.7 A˚ RMSD on Ca). In addition,
from the ED projections (Fig. 2), it can be seen that
the structural changes during free MD simulation of the
nonoptimized structure are ballistic and indicative of high
levels of internal strain in the protein structure, in contrast
to the simulations of the optimized structure, which are
diffusive, which is a characteristic of stable, native-state
protein structures (37). These are clear effects of the
controlled-release optimization method employed that
minimizes structural changes in the active site region while
TABLE 6 Substrates and other compounds with known activity in StyA*
Dockingy Calculated afﬁnity§{ Inhibition§
Substrate Distance Orientation Pred. act. Exp. Act.z DG (kCal/mol)k Kd (nM) Predicted** Exp
yy
Styrene 1 1 1 1 9.0 6 1.2 162 — —
3-Methyl-styrene –/1 1 1 1 9.4 6 2.2 73 — —
4-Methyl-styrene 1 1 1 1 10.8 6 1.4 6.6 25 0.2
a-Methyl-styrene 1 1 1 1 8.7 6 1.2 242 0.7 0.08
b-Methyl-styrene 1/1 1/1 1/1 1 10.8 6 1.2 6.6 25 1.5
3-Bromostyrene –/1 – – 1 – — — —
4-Bromostyrene 1 1 1 1 – — — —
3-Chlorostyrene 1/1 –/1 1 1 – — — —
4-Chlorostyrene – – – 1 – — — —
3-Nitrostyrene 1/1 –/– – 1 – — — —
4-Nitrostyrene 1 – – 1 – — — —
1,2-Dihydro-naphthalene 1/1 1/– 1 1 10.6 6 1.6 9.8 — —
Indene 1 1 1 1 10.1 6 1.4 22 — —
1-Phenyl-1-cyclohexen 1 1 1 o – — — —
2-Vinylpyridine 1/o 1/– 1/o o 11.5 6 2.9 2.0 — —
Allylbenzol 1 1 1 o 8.7 6 1.7 242 — —
1,3-Cyclo-heptadiene 1 1 1 – 8.3 6 1.4 539 — —
4-Vinylpyridine 1 1 1 – 9.9 6 2.9 33 — —
cis,cis-1,3-Cyclooctadiene 1 1 1 – – — — —
Naphthalene 1 1 1 – 8.7 6 1.4 242 — —
Vinylcyclopentane 1/1 1/1 1/1 – 8.1 6 1.2 805 — —
*Distances, orientation, and predicted activity (pred. act.) from docking, and measured activities (Exp. Act.), calculated binding afﬁnities (DG and Kd cf. Eq.
(2)) and predicted (pred) and experimental (exp) inhibition from LIE are listed.
yBinding distance (dist) and orientation (orient) from automated docking: active (1), intermediate (o) and nonactive (). Alternate docking solutions are
separated by a slash (/).
zExperimental versus predicted styrene activity (pred, i.e., ‘active’ binding distance and orientation) and experimental (exp): high (‘1’, .20%), low (‘o’,
,20%) or no (‘’, ,1%).
§‘—’, ‘not determined’.
{Binding free energy DG (kcal/mol) and afﬁnity Kd (nM) calculated using the LIE method.
kError margins derived from energy ﬂuctuations during MD simulations.
**Relative inhibition versus styrene calculated as KStyd;Calc=Kd;Calc.yyInhibition measured experimentally as relative rate of epoxidation versus styrene at equimolar concentrations of 1 mM.
FIGURE 3 Calculated binding free energies (DGcalc) for 13 of the sub-
strates, as listed in Table 6, following the ordering and classiﬁcation of ex-
perimental activities as in Table 6.
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allowing the rest of the protein structure to relax signiﬁ-
cantly.
StyA structure validation with experimental data
For the 13 mutants of StyA studied (Table 4 and Fig. 1 B), a
clear correlation was observed between the distance of a
mutation site to the closest of the styrene and FAD binding
sites and the maximum effect of the substitutions on the
measured enzyme activity, indicating a good overall align-
ment of StyA with the template structure. The P302
substitutions are particularly worth mentioning. The P302H
mutant has a low measured activity for styrene (,10%
versus WT), and styrene is predicted to bind very tightly (DG
, 11 kcal/mol, Kd , 1 nM) but too far away for catalysis
(;10 A˚) (see Table 4). It appears that the histidine at position
302, which is located just above the isoalloxazine ring of
FAD, may block access to the catalytic site in StyA (see Fig.
1 C). Alternately, the P302H mutation could affect the
structure or stability of the bD3-aH10 loop. The P302A
mutant has a low measured activity (10%), but the predicted
binding afﬁnity of styrene is comparable to WT (DG  9
kcal/mol, Kd  100 nM), and it binds close enough for
catalysis (;6.5 A˚). Possibly, changing the stiff proline for
the more ﬂexible alanine adversely affects the protein’s
stability, as is indeed also seen from the increased appear-
ance of inclusion bodies (5). In the V274C mutant, styrene is
predicted to bind strongly (DG ¼ 10.1 kcal/mol, Kd ¼ 24
nM), but at too large distance (.7 A˚) to be actively
metabolized (Table 4).
All 21 compounds studied (Table 6) could be docked into
the active site cavity. For 13 compounds (Table 6), afﬁnities
were predicted using the LIE method. As a trend, the active
compounds showed a higher predicted afﬁnity, although for
individual cases the error margins are such that signiﬁcance is
minimal. In addition, it must be borne in mind that in other
cases too, the actual binding afﬁnity couldwell be the limiting
factor for efﬁcient turnover. Only 3-bromo-, 4-chloro-, and 3-
and 4-nitrostyrene were predicted to bind in an orientation
unsuited for metabolism, whereas they were nevertheless
metabolized in our experiment. This might be attributed to the
chemical nature of the relatively large, electron-rich, and
polarizable bromo-, chloro- and nitro- substituents, whose
properties are difﬁcult to describe appropriately in a force ﬁeld
or scoring function. The two substrates with lowest predicted
afﬁnity (.250 nM; cycloheptadiene and vinylcyclopentane)
lack the characteristic aromatic six-membered ring and are
also experimentally inactive. The other substrate that lacks the
aromatic ring is cyclooctadiene, which, although predicted to
bind in the right place and at good afﬁnity, is not catalyzed
(Table 6). This leads to the tentative conclusion that the
aromatic six-membered ring might be important for binding
and essential for catalysis. The ﬁnal StyA structure has been
deposited in the PDB under ID 2HD8.
The StyA active site and styrene and FAD
binding regions
A close look at the styrene binding cavity and active site
revealed that the hydroxyl group of Tyr47 and carbonyl group
of Pro302 are at;4 A˚ from the catalytic FC4A of FAD and the
ethylene group of styrene in an otherwise completely hydro-
phobic binding cavity (at the rear and front, respectively, in
Fig. 1 C). The corresponding Pro293 in pHBH (Table 2) is
implicated in stabilization of intermediate state(s) of the
FIGURE 4 FAD and water binding in the
StyA active site. Residues in the read are
labeled with a smaller font. The substrate
styrene is shown as well. Hydrogen bonds
among FAD, selected binding residues, and
selected water molecules are indicated with
dashed yellow lines. Waters are highlighted
with transparent light-blue spheres.
TABLE 7 Active site residues with at least one atom within 6 A˚
from at least one atom of the bound styrene*
Sec. struct. element Active site residues Location in active sitey
bE1 Leu45, Thr47, Val48 Rear
bB6 Ile198, Thr200 Front bottom, access channel
bB4 Leu220, Glu221, Val222 Bottom left
bB5 Arg233, Ala234, Phe235 Bottom (center)
bB7 Val274 Front right, access channel
aH9b Pro302, Val303, Gly305 Top, access channel
Cofactor FAD Right
*Location in secondary structure elements and in space around the binding
pocket for the StyA protein model are indicated. For completeness the FAD
cofactor is also listed. Five residues with atoms closer than 3.5 A˚ constitute
the main binding residues and are marked in bold; the three that are not
actually at the pocket surface are marked in italics.
ySee Fig. 1 C.
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reaction (15), which suggests that the Pro302 and Thr47 are
important for catalytic activity in StyA. Most discussion
in literature on the importance of water molecules in the
pHBH catalytic function, appears to have been focused on a
hydrogen-bonded water network in the active site cavity
bridging the substrate and the putative catalytic Pro293 with
the bulk water through the FAD binding pocket (39,40).
Likewise, the strongly hydrophobic StyA styrene binding
cavity of the StyAmodel contains nowatermolecules (Fig. 4),
but three water molecules were hydrogen-bonded to the FAD
side of the P302 carbonyl and form a hydrogen-bonded
network with the backbone of residues 301, 302, 306, and 307
and the ﬂavin ribityl of FAD (Fig. 4). In the crystal structures
of pHBH an arrangement of water molecules is present,
involving the active-site P293 carbonyl, which is very similar
to that found in the currentmodel. It should be noted that in the
StyAmodel the crystal waters of the pHBH template structure
were excluded, and the StyA protein structure was resolvated
and equilibrated in water for theMD simulations. Thesewater
molecules have been suggested to be involved in the catalytic
mechanism of pHBH for proton donation as well as stabili-
zation of intermediate state(s) (40), which leads to the
compelling suggestion that also in StyA, these waters are
critical for catalysis.
CONCLUSIONS
A ﬁrst homology model of StyA has been constructed and
optimized using molecular dynamics simulations. For all key
residues for ligand and cofactor binding and for catalytic
activity, known from the template pHBH protein, correspond-
ing counterparts in the StyA sequence and structure could be
identiﬁed.Known experimental data on enantioselectivity and
catalytic activity of styrene in StyA wild types and mutants
and of different substrates in thewild-type StyA corresponded
well with predicted substrate binding orientations and afﬁn-
ities based on this StyA homologymodel. The StyA active site
residues Thr47 and Pro302 are critical in StyA catalysis and are
possibly involved in the stabilization of reaction intermedi-
ate(s). The remainder of the styrene binding pocket is exclu-
sively hydrophobic and consists of Phe235, Val303, Leu220, the
di-methyl-phenyl ring of FAD, Ile198, and Val222, where
styrene binds stacked between Phe235 and Val303. The model
structure of StyA is deposited in the PDBunder ID 2HD8. The
current StyAproteinmodel thus provides a good starting point
for further validation of the role of the active site residues and
FADcofactor binding residues in ligandbinding and catalysis.
Novel insights in the active site topology and in the binding of
ligands in SMO/StyA may facilitate the rational design of
mutants with speciﬁc, altered enantioselective properties.
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